What causes cancer and how can we find better ways to treat it?
Training our immune system to recognize and attack tumors – immunotherapy – holds great promise for cancer therapy. New research by scientists from VIB, VUB, UGent, KU Leuven, and international partner Roche now shows why some patients don’t respond to immunotherapy. By clarifying the role of different cell types involved in the immune system’s response, this work by the team of Prof. Damya Laoui is an important step toward personalized treatment for cancer patients and is published in Cancer Research.
August 18, 2022
Novel monoclonal antibody developed based on research of Peter Carmeliet and Rakesh Jain shows promising Phase I results by halting disease progression in aggressive pediatric brain cancer
July 19, 2022
Our lymphatic vasculature is part of our circulatory system and it carries 'lymph' through our body. This is crucial to maintain internal fluid levels, transport immune cells to their location, and for fat absorption. New work by the team of Prof. Patrizia Agostinis (VIB-KU Leuven Center for Cancer Biology and the Department of Cellular and Molecular Medicine at KU Leuven) shows how autophagy shapes our lymphatic system. Their results appear in the journal Nature Communications.
May 23, 2022
Breast cancer became the world's most diagnosed cancer in 2021. While survival rates are high, metastasis can reduce these drastically. New research by the team of Prof. Dr. Sarah-Maria Fendt (VIB-KU Leuven Center for Cancer Biology) and international partners shows how changing levels of the protein PHGDH enable breast cancer cells to travel through the body. The results appear in the leading journal Nature.
May 18, 2022